KURT BOEHRINGER, M.D.; PETER WEIDMANN, M.D.; RUBINO MORDASINI, M.D.; HELMUT SCHIFFL, M.D.; CLAUDE BACHMANN, M.D.; WALTER RIESEN, Ph.D.
The effects of chlorthalidone, 100 mg/d given for 6 weeks, on serum lipids and lipoproteins were assessed in 22 premenopausal and 18 postmenopausal women. In the latter, chlorthalidone significantly increased total serum cholesterol (13%, p < 0.001), low-density-lipoprotein (LDL) cholesterol (21%, p < 0.001) and apoprotein B (16%, p < 0.05). In contrast, these values were not altered in the premenopausal group. Levels of LDL cholesterol, high-density-lipoprotein cholesterol, total and very-low-density triglycerides, apoproteins A1 and A2, and plasma volume, plasma glucose, insulin, epinephrine, estradiol, and free fatty acids were unchanged in both groups. Chlorthalidone-induced changes in levels of LDL cholesterol did not correlate significantly with variations in blood pressure, plasma potassium, uric acid, renin, aldosterone, or norepinephrine levels. These findings indicate that the thiazide-like diuretic chlorthalidone increases serum LDL cholesterol in postmenopausal but not in premenopausal women.
BOEHRINGER K, WEIDMANN P, MORDASINI R, SCHIFFL H, BACHMANN C, RIESEN W. Menopause-Dependent Plasma Lipoprotein Alterations in Diuretic-Treated Women. Ann Intern Med. ;97:206–209. doi: 10.7326/0003-4819-97-2-206
Download citation file:
Published: Ann Intern Med. 1982;97(2):206-209.
Cardiology, Coronary Risk Factors, Dyslipidemia.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use